HB 33 – New Mexico

Status: In Process
Year Introduced: 2024
Link: https://www.nmlegis.gov/Legislation/Legislation?Chamber=H&LegType=B&LegNo=33&year=24

Relating to prescription drugs; enacting the prescription drug price transparency act to increase transparency across the prescription drug supply chain; requiring prescription drug manufacturers, pharmacy services administrative organizations, health insurers and pharmacy benefits managers to report prescription drug price trends to the superintendent of insurance; requiring the superintendent of insurance to collect and publicly report aggregate information on prescription drug price trends; prescribing civil penalties; making an appropriation.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found